ZCCHC12 anticorps (N-Term)
-
- Antigène Voir toutes ZCCHC12 Anticorps
- ZCCHC12 (Zinc Finger, CCHC Domain Containing 12 (ZCCHC12))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ZCCHC12 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- ZCCHC12 antibody was raised against the N terminal of ZCCHC12
- Purification
- Affinity purified
- Immunogène
- ZCCHC12 antibody was raised using the N terminal of ZCCHC12 corresponding to a region with amino acids AREVMRVLQATNPNLSVADFLRAMKLVFGESESSVTAHGKFFNTLQAQGE
- Top Product
- Discover our top product ZCCHC12 Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ZCCHC12 Blocking Peptide, catalog no. 33R-1469, is also available for use as a blocking control in assays to test for specificity of this ZCCHC12 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ZCCHC12 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- ZCCHC12 (Zinc Finger, CCHC Domain Containing 12 (ZCCHC12))
- Autre désignation
- ZCCHC12 (ZCCHC12 Produits)
- Synonymes
- anticorps PNMA7A, anticorps SIZN, anticorps SIZN1, anticorps 2810028A01Rik, anticorps AV136720, anticorps Sizn1, anticorps zinc finger CCHC-type containing 12, anticorps sterile alpha motif domain containing 12, anticorps zinc finger, CCHC domain containing 12, anticorps ZCCHC12, anticorps samd12, anticorps Zcchc12
- Sujet
- ZCCHC12 contains 1 CCHC-type zinc finger. ZCCHC12 is the transcriptional coactivator in the bone morphogenetic protein (BMP)-signaling pathway. It positively modulates BMP signaling by interacting with SMAD1 and associating with CBP in the transcription complex. It contributes to the BMP-induced enhancement of cholinergic-neuron-specific gene expression.
- Poids moléculaire
- 45 kDa (MW of target protein)
-